ethambutol has been researched along with Disease Models, Animal in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (16.67) | 18.7374 |
| 1990's | 8 (22.22) | 18.2507 |
| 2000's | 8 (22.22) | 29.6817 |
| 2010's | 12 (33.33) | 24.3611 |
| 2020's | 2 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Bhakta, S; Boshoff, HI; Evangelopoulos, D; Gibbons, S; Gunaratnam, M; Lenaerts, A; Malkinson, JP; Moreira, JB; Neidle, S; O'Donnell, G; Poeschl, R; Zimhony, O | 1 |
| Angulo-Barturen, I; Beltrán, M; Cáceres, N; Cardona, PJ; García, JI; García-Bustos, JF; Rullas, J | 1 |
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Cao, LH; Kang, L; Liu, HJ; Miao, JX; Miao, MS; Miao, YY; Song, YG; Xiang, LL | 1 |
| Bakker-Woudenberg, IAJM; Davies, GR; de Knegt, GJ; de Steenwinkel, JEM; Dickinson, L; Evangelopoulos, D; McHugh, TD; Pertinez, H | 1 |
| Bax, HI; de Knegt, GJ; de Steenwinkel, JEM; Mourik, BC; Mouton, JW; Verbon, A | 1 |
| Bhatta, RS; Chauhan, S; Chopra, S; Dasgupta, A; Gupta, P; Gupta, UD; Karaulia, P; Puttrevu, SK; Singh, AK; Singh, VK; Tadigoppula, N; Yadav, P | 1 |
| Luukinen, H; Myllymäki, H; Niskanen, M; Parikka, M; Rämet, M | 1 |
| Bax, HI; de Knegt, GJ; de Steenwinkel, JEM; Mourik, BC; Simonsson, USH; Svensson, RJ; Verbon, A | 1 |
| Coates, AR; Davies, GR; Gillespie, SH; Hu, Y; Liu, Y; Pertinez, H | 1 |
| Betoudji, F; Lanoix, JP; Nuermberger, E | 1 |
| Adamson, J; Almeida, DV; Ammerman, NC; Bester, LA; Dorasamy, A; Grosset, JH; Mgaga, Z; Moodley, C; Moodley, S; Ngcobo, B; Singh, SD; Swanson, RV | 1 |
| Alameda, L; Chen, C; Ferrer, S; Ortega, F; Simonsson, US | 1 |
| Almeida, D; Grosset, JH; Karakousis, PC; Mdluli, KE; Nuermberger, EL; Peloquin, CA; Rosenthal, IM; Tasneen, R; Zhang, M | 1 |
| Iwata, N; Kimotsuki, T; Kinoshita, J; Maejima, T; Yasuda, M | 1 |
| Bermudez, LE; Inderlied, CB; Kolonoski, P; Petrofsky, M; Wu, M; Young, LS | 1 |
| Boelaert, RJ; Grosset, J; Lounis, N; Maslo, C; Truffot-Pernot, C | 1 |
| Cynamon, MH; Sklaney, M; Yeo, AE | 1 |
| Chen, P; Einck, L; Gearhart, J; Hanrahan, C; Nacy, CA; Nikonenko, B; Protopopova, M; Samala, R | 1 |
| Almeida, D; Bishai, WR; Grosset, JH; Nuermberger, E; Peloquin, CA; Rosenthal, I; Tyagi, S; Williams, KN | 1 |
| Kuze, F | 1 |
| Durr, FE; Thomas, JP | 1 |
| Graybill, JR; Moreno, F; Valero, G | 1 |
| Brummer, E; Deresinski, SC; Hamilton, JR; Kemper, CA; Sison, JP; Stevens, DA; Yao, Y | 1 |
| Bermudez, LE; Inderlied, CB; Nash, KA; Petrofsky, M; Young, LS | 1 |
| Chase, SE; Cynamon, MH; Lenaerts, AM | 1 |
| Kaur, D; Khuller, GK | 1 |
| Cohen, Y; Grosset, J; Perronne, C; Pocidalo, JJ; Truffot-Pernot, C; Vildé, JL | 1 |
| Cynamon, MH; DeStefano, MS; Klemens, SP | 1 |
| Skakun, NP; Tabachuk, OE | 1 |
| Neumeyer, C; Spekreijse, H; Wietsma, JJ | 1 |
| Byrne, C; Clancy, LJ; Costello, E; Kelly, P; O'Reilly, L | 1 |
| Rosenfeld, M | 1 |
| Horai, Z; Matsumura, K; Shimizu, K; Ueda, Y; Yoneda, H | 1 |
| Drabkina, RO; Ginzburg, TS | 1 |
| Kradolfer, F; Schnell, R | 1 |
1 trial(s) available for ethambutol and Disease Models, Animal
| Article | Year |
|---|---|
Treatment of Myocardium avium complex infection: does the beige mouse model predict therapeutic outcome in humans?
Topics: AIDS-Related Opportunistic Infections; Animals; Antitubercular Agents; Clofazimine; Colony Count, Microbial; Disease Models, Animal; Ethambutol; Humans; Liver; Mice; Mycobacterium avium-intracellulare Infection; Rifampin; Species Specificity; Spleen | 1996 |
35 other study(ies) available for ethambutol and Disease Models, Animal
| Article | Year |
|---|---|
Bioactive pyridine-N-oxide disulfides from Allium stipitatum.
Topics: 2,2'-Dipyridyl; Alkaloids; Allium; Animals; Anti-Bacterial Agents; Antineoplastic Agents, Phytogenic; Disease Models, Animal; Disulfides; Drug Resistance, Multiple; Drug Screening Assays, Antitumor; Heat-Shock Proteins; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Molecular Structure; Oxyquinoline; Pyridines; Thioredoxins; Vitamin K 3 | 2009 |
Fast standardized therapeutic-efficacy assay for drug discovery against tuberculosis.
Topics: Acetamides; Animals; Antitubercular Agents; Aza Compounds; Disease Models, Animal; Drug Discovery; Ethambutol; Fluoroquinolones; Immunocompetence; Inhalation Exposure; Isoniazid; Linezolid; Mice; Mice, Inbred C57BL; Moxifloxacin; Oxazolidinones; Pyrazinamide; Quinolines; Reproducibility of Results; Rifampin; Tuberculosis, Pulmonary | 2010 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Total glucosides of herbaceous peony (Paeonia lactiflora Pall.) flower attenuate adenine- and ethambutol-induced hyperuricaemia in rats.
Topics: Adenine; Animals; Biomarkers; Disease Models, Animal; Down-Regulation; Ethambutol; Flowers; Glucosides; Hyperuricemia; Kidney; Male; Paeonia; Plant Extracts; Rats, Wistar; Uric Acid; Uricosuric Agents | 2020 |
Assessment of treatment response by colony forming units, time to culture positivity and the molecular bacterial load assay compared in a mouse tuberculosis model.
Topics: Animals; Antitubercular Agents; Bacterial Load; Colony Count, Microbial; Disease Models, Animal; DNA, Bacterial; Ethambutol; Female; Isoniazid; Lung; Mice, Inbred BALB C; Mycobacterium tuberculosis; Nonlinear Dynamics; Predictive Value of Tests; Pyrazinamide; Ribotyping; Rifampin; RNA, Ribosomal, 16S; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 2017 |
Assessment of Bactericidal Drug Activity and Treatment Outcome in a Mouse Tuberculosis Model Using a Clinical Beijing Strain.
Topics: Animals; Antitubercular Agents; Disease Models, Animal; Drug Therapy, Combination; Ethambutol; Female; Isoniazid; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Treatment Outcome; Tuberculosis, Pulmonary | 2017 |
Biological evaluation of novel curcumin-pyrazole-mannich derivative active against drug-resistant Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Bacterial Load; Curcumin; Disease Models, Animal; Drug Combinations; Drug Synergism; Ethambutol; Female; Humans; Mannich Bases; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Pyrazoles; Time Factors; Tuberculosis, Multidrug-Resistant | 2017 |
Identification of protective postexposure mycobacterial vaccine antigens using an immunosuppression-based reactivation model in the zebrafish.
Topics: Animals; Antigens, Bacterial; Bacterial Load; Biomarkers; Dexamethasone; Disease Models, Animal; Ethambutol; Granuloma; Hypoxia; Immunosuppression Therapy; Lymphocyte Depletion; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; T-Lymphocytes; Tuberculosis Vaccines; Zebrafish | 2018 |
Improving treatment outcome assessment in a mouse tuberculosis model.
Topics: Administration, Oral; Animals; Antitubercular Agents; Disease Models, Animal; Drug Therapy, Combination; Ethambutol; Female; Genotype; Humans; Mice; Mice, Inbred BALB C; Models, Theoretical; Moxifloxacin; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis | 2018 |
Moxifloxacin Replacement in Contemporary Tuberculosis Drug Regimens Is Ineffective against Persistent Mycobacterium tuberculosis in the Cornell Mouse Model.
Topics: Animals; Antitubercular Agents; Disease Models, Animal; Drug Therapy, Combination; Ethambutol; Female; Isoniazid; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Moxifloxacin; Mycobacterium tuberculosis; Recurrence; Tuberculosis, Pulmonary | 2018 |
Sterilizing Activity of Pyrazinamide in Combination with First-Line Drugs in a C3HeB/FeJ Mouse Model of Tuberculosis.
Topics: Animals; Antitubercular Agents; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Isoniazid; Mice, Inbred BALB C; Mice, Inbred C3H; Mutation; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2016 |
Clofazimine Contributes Sustained Antimicrobial Activity after Treatment Cessation in a Mouse Model of Tuberculosis Chemotherapy.
Topics: Animals; Antitubercular Agents; Clofazimine; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Ethambutol; Female; Isoniazid; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis; Withholding Treatment | 2016 |
Population pharmacokinetics, optimised design and sample size determination for rifampicin, isoniazid, ethambutol and pyrazinamide in the mouse.
Topics: Animals; Antibiotics, Antitubercular; Disease Models, Animal; Ethambutol; Isoniazid; Mice, Inbred C57BL; Models, Biological; Pyrazinamide; Rifampin; Sample Size | 2016 |
Dose-ranging comparison of rifampin and rifapentine in two pathologically distinct murine models of tuberculosis.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Isoniazid; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Random Allocation; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2012 |
Retinal function and morphology in monkeys with ethambutol-induced optic neuropathy.
Topics: Administration, Oral; Animals; Antitubercular Agents; Dark Adaptation; Disease Models, Animal; Electroretinography; Ethambutol; Macaca fascicularis; Microglia; Necrosis; Nerve Fibers; Optic Nerve Diseases; Photic Stimulation; Retina; Retinal Ganglion Cells | 2012 |
Mefloquine, moxifloxacin, and ethambutol are a triple-drug alternative to macrolide-containing regimens for treatment of Mycobacterium avium disease.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antimalarials; Aza Compounds; Clarithromycin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Mefloquine; Mice; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Quinolines | 2003 |
Impact of iron loading on the activity of isoniazid or ethambutol in the treatment of murine tuberculosis.
Topics: Animals; Antitubercular Agents; Disease Models, Animal; Drug Interactions; Ethambutol; Female; Iron; Isoniazid; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Survival Rate; Time Factors; Treatment Outcome; Tuberculosis | 2003 |
The activity of grepafloxacin in two murine models of Mycobacterium avium infection.
Topics: Administration, Intranasal; Animals; Clarithromycin; Disease Models, Animal; Ethambutol; Female; Fluoroquinolones; Injections, Intravenous; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mycobacterium avium Complex; Piperazines; Random Allocation; Rifabutin | 2004 |
Identification of a new antitubercular drug candidate, SQ109, from a combinatorial library of 1,2-ethylenediamines.
Topics: Animals; Antitubercular Agents; Cell Survival; Chlorocebus aethiops; Colony Count, Microbial; Combinatorial Chemistry Techniques; Disease Models, Animal; Ethambutol; Ethylenediamines; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Tuberculosis; Vero Cells | 2005 |
Combination chemotherapy with the nitroimidazopyran PA-824 and first-line drugs in a murine model of tuberculosis.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Disease Models, Animal; Drug Therapy, Combination; Ethambutol; Female; Isoniazid; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Nitroimidazoles; Pyrazinamide; Rifampin; Secondary Prevention; Time Factors; Tuberculosis, Pulmonary | 2006 |
Experimental chemotherapy in chronic Mycobacterium avium-intracellulare infection of mice.
Topics: Animals; Antitubercular Agents; Chronic Disease; Cycloserine; Disease Models, Animal; Drug Therapy, Combination; Ethambutol; Kanamycin; Liver; Lung; Male; Mice; Mycobacterium avium; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Rifampin; Spleen; Time Factors | 1984 |
Ethambutol dose-plasma level correlation studies in guinea pigs.
Topics: Animals; Disease Models, Animal; Ethambutol; Female; Guinea Pigs; Male; Tuberculosis | 1983 |
Activities of clarithromycin, ofloxacin, and clarithromycin plus ethambutol against Mycobacterium simiae in murine model of disseminated infection.
Topics: Animals; Clarithromycin; Disease Models, Animal; Drug Therapy, Combination; Ethambutol; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Mycobacterium; Ofloxacin; Skin Diseases, Bacterial; Splenic Diseases | 1994 |
Effect of ethambutol on emergence of clarithromycin-resistant Mycobacterium avium complex in the beige mouse model.
Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Disease Models, Animal; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Genes, Bacterial; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Mutagenesis, Site-Directed; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; RNA, Ribosomal, 23S; Spleen | 1996 |
Evaluation of rifalazil in a combination treatment regimen as an alternative to isoniazid-rifampin therapy in a mouse tuberculosis model.
Topics: Animals; Antitubercular Agents; Colony-Forming Units Assay; Disease Models, Animal; Drug Therapy, Combination; Ethambutol; Female; Isoniazid; Mice; Pyrazinamide; Rifampin; Rifamycins; Tuberculosis | 2000 |
In vitro, ex-vivo and in vivo activities of ethambutol and sparfloxacin alone and in combination against mycobacteria.
Topics: Animals; Anti-Infective Agents; Antitubercular Agents; Colony Count, Microbial; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Mice; Microbial Sensitivity Tests; Mycobacterium avium; Mycobacterium Infections, Nontuberculous; Mycobacterium smegmatis; Mycobacterium tuberculosis; Tuberculosis | 2001 |
Sparfloxacin, ethambutol, and cortisol receptor inhibitor RU-40 555 treatment for disseminated Mycobacterium avium complex infection of normal C57BL/6 mice.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Therapy, Combination; Ethambutol; Feasibility Studies; Female; Fluoroquinolones; Glucocorticoids; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mifepristone; Mycobacterium avium; Quinolones; Receptors, Glucocorticoid; Spleen; Time Factors; Tuberculosis | 1992 |
Activity of clarithromycin against Mycobacterium avium complex infection in beige mice.
Topics: Amikacin; Animals; Anti-Infective Agents; Antitubercular Agents; Clarithromycin; Clofazimine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; Humans; Mice; Mice, Inbred C57BL; Mycobacterium avium; Mycobacterium avium Complex; Quinolones; Rifabutin; Rifampin; Rifamycins; Time Factors; Tuberculosis | 1992 |
[Comparative hepatic toxicity of isoniazid, rifampicin and ethambutol].
Topics: Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Dose-Response Relationship, Drug; Ethambutol; Isoniazid; Liver; Liver Function Tests; Male; Rats; Rifampin | 1991 |
Induced color blindness in goldfish: a behavioral and electrophysiological study.
Topics: Animals; Color Perception; Color Vision Defects; Disease Models, Animal; Electroretinography; Ethambutol; Goldfish; Neurons; Photoreceptor Cells; Sensory Thresholds | 1991 |
The pathogenicity of Mycobacterium tuberculosis during chemotherapy.
Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Disease Models, Animal; Drug Therapy, Combination; Ethambutol; Fluorescent Antibody Technique; Guinea Pigs; Humans; Injections, Subcutaneous; Isoniazid; Mycobacterium tuberculosis; Rifampin; Sputum; Tuberculosis, Pulmonary | 1990 |
[Chemotherapy of so-called atypical mycobacterioses].
Topics: Animals; Antitubercular Agents; Cycloserine; Dapsone; Disease Models, Animal; Drug Synergism; Ethambutol; Ethionamide; Mice; Mycobacterium Infections; Phenylthiourea; Rabbits; Streptomycin; Thioacetazone | 1968 |
[Induction of Mycobacterium infection by introduction of the organisms into the lung through an intratracheal vinyl tube].
Topics: Animals; Antibiotics, Antitubercular; Disease Models, Animal; Dust; Ethambutol; Guinea Pigs; Intubation, Intratracheal; Isoniazid; Kanamycin; Mycobacterium tuberculosis; Silicon Dioxide; Tuberculosis, Pulmonary | 1972 |
[Antitubercular activity and concentrations of rifampicin and ethambutol in the organs].
Topics: Animals; Disease Models, Animal; Ethambutol; Mice; Rifampin; Tuberculosis | 1973 |
The combination of rifampicin and other antituberculous agents in chronic murine tuberculosis.
Topics: Animals; Cell Count; Chronic Disease; Disease Models, Animal; Drug Synergism; Ethambutol; Ethionamide; Isoniazid; Lung; Mice; Placebos; Rifampin; Streptomycin; Tuberculosis | 1971 |